The International Association of Forensic Toxicologists
Join us at TIAFT 2024 and discover how we can help you expand your drug-testing menu and enhance your productivity.
Conference date: September 2nd – 6th, 2024
Location: St. Gallen, Switzerland
Venue: Olma Messen
Maps
The Viva-ProE® System with EMIT® technology helps to optimize your facility’s drug-testing performance by delivering efficient results through a compact benchtop design. The Viva-ProE System supports a flexible approach to dedicated drug-testing analysis, enabling greater ease of use, workstation efficiency, and a full drug-testing menu, all in one powerful system.
The Atellica® CH 930 Analyzer with EMIT® technology provides flexible testing for a variety of toxicology labs. The system is available with Atellica Integrated Automation to streamline critical pre- and post-analytical tasks, including decapping, sealing and automatic sorting for drug confirmation testing, with little to no additional footprint. The system offers a full drug-testing menu with high precision, accuracy, and reproducibility.
Since 1972, Syva® Emit® has been the trusted brand in drug testing. Syva Emit reagents are among the most widely used and extensively validated reagents in the industry. Siemens Healthineers has a comprehensive menu to meet the needs of a variety of testing environments.
Interested in learning more?
Congress information
Want to learn more about TIAFT 2024 and The International Association of Forensic Toxicologists?
Share
Do you find this page interesting? Share it with your peers.
Product availability may vary from country to country and is subject to varying regulatory requirements. Please contact your local representative for availability.
Viva™ systems are manufactured by ELITech Group and distributed by Siemens Healthineers.
Atellica, Dimension, Emit, RxL Max, StreamLAB, Syva, Viva, Viva Pro-E, and all associated marks are trademarks of Siemens Healthcare Diagnostics, Inc., or its affiliates. All other trademarks and brands are the property of their respective owners.